Asia · Markets & Finance · CNBC-TV18

Lupin gets US FDA nod for vitamin K injection with $52 million US market

Published by CNBC-TV18 · India 6 h ago

Lupin has received US FDA approval for a prefilled vitamin K injection used to treat low blood clotting and vitamin K deficiency, with $52.3 million in annual US sales.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Tech in Asia

SoftBank, Grab explore AI infrastructure in Sarawak

Mint

ROI-Five charts sounding the alarm for stretched US markets: McGeever

SCMP Business

Hong Kong’s AI Marketing Moment is Here. The Question is Whether Business Leaders are Moving Fast Enough

The Business Times

Family offices see more tailored products, leverage ‘collective firepower’ for direct deal access

The Economic Times

US stocks: S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh

Caixin Global